Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Pilot Projects in Aging

McMaster University

$46,944.00

Immune and Genetic Correlates of Response to Zoster Vaccine in the Frail Elderly

EF 2008-09

Résumé
With aging, the ability of the immune system wanes. This can lead to an impaired vaccine response in the elderly. In this pilot study we propose to study the immune response to herpes zoster vaccine in elderly residents of nursing homes. Residents of nursing homes, a high risk population for herpes zoster, may benefit from the vaccine. However, the Shingles Prevention Study (SPS), a large randomized trial that found an overall efficacy of 51% in preventing zoster in the elderly, excluded individuals with conditions that might interfere with study evaluations including cognitive impairment, non-ambulatory status, and those with expected survival less than 5 years. In this proposal, we will 1) assess the response of the zoster vaccine in the frail elderly, 2) assess whether there are immune markers associated with a response, and 3) assess whether there are genetic determinants associated with an increased response. We believe that this exploratory study will lay the groundwork for a larger study that will yield new insight into the mechanisms of how immunity wanes in the elderly and response to zoster vaccine in the frail elderly.
Programme
Catalyst Grant: Pilot Projects in Aging
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
180247
Name
Loeb Mark B
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
Institute of Aging Pilot Projects
Projecttitle
Immune and Genetic Correlates of Response to Zoster Vaccine in the Frail Elderly
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$46,944
Cihrequipment2
$0
Programname2
Catalyst Grant: Pilot Projects in Aging
Keyworddelim
Cohort Study; Correlates Of Immune Protection; Nursing Home Elderly; Zoster Vaccine
Abstract
With aging, the ability of the immune system wanes. This can lead to an impaired vaccine response in the elderly. In this pilot study we propose to study the immune response to herpes zoster vaccine in elderly residents of nursing homes. Residents of nursing homes, a high risk population for herpes zoster, may benefit from the vaccine. However, the Shingles Prevention Study (SPS), a large randomized trial that found an overall efficacy of 51% in preventing zoster in the elderly, excluded individuals with conditions that might interfere with study evaluations including cognitive impairment, non-ambulatory status, and those with expected survival less than 5 years. In this proposal, we will 1) assess the response of the zoster vaccine in the frail elderly, 2) assess whether there are immune markers associated with a response, and 3) assess whether there are genetic determinants associated with an increased response. We believe that this exploratory study will lay the groundwork for a larger study that will yield new insight into the mechanisms of how immunity wanes in the elderly and response to zoster vaccine in the frail elderly.
Competitiondate
200903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Loeb, Mark B
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $46,944~ $0~